Francois Brisebois
Stock Analyst at Oppenheimer
(1.13)
# 3,676
Out of 4,905 analysts
91
Total ratings
30.77%
Success rate
-13.78%
Average return
Main Sectors:
Stocks Rated by Francois Brisebois
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNSE Sensei Biotherapeutics | Maintains: Outperform | $70 → $80 | $7.84 | +920.41% | 2 | Mar 28, 2025 | |
| ABEO Abeona Therapeutics | Initiates: Outperform | $16 | $6.59 | +142.79% | 1 | Mar 5, 2025 | |
| OVID Ovid Therapeutics | Upgrades: Outperform | $4 | $0.55 | +627.27% | 1 | Jan 29, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Outperform | $65 → $72 | $43.24 | +66.51% | 7 | Jan 22, 2025 | |
| HRMY Harmony Biosciences Holdings | Maintains: Outperform | $59 → $61 | $35.20 | +73.30% | 6 | Jan 13, 2025 | |
| MNMD Mind Medicine (MindMed) | Reiterates: Outperform | $20 | $8.88 | +125.23% | 4 | Dec 17, 2024 | |
| TRDA Entrada Therapeutics | Maintains: Outperform | $25 → $28 | $6.26 | +347.28% | 2 | Nov 6, 2024 | |
| AVDL Avadel Pharmaceuticals | Maintains: Outperform | $29 → $30 | $10.83 | +177.01% | 8 | Oct 31, 2024 | |
| PRAX Praxis Precision Medicines | Maintains: Outperform | $143 → $163 | $53.85 | +202.69% | 4 | Oct 31, 2024 | |
| DYN Dyne Therapeutics | Reiterates: Outperform | $55 | $9.02 | +509.76% | 5 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $15 | $5.74 | +161.32% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $6 | $4.18 | +43.54% | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $11 | $2.68 | +310.45% | 6 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $15.69 | -10.77% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $13 → $15 | $4.20 | +257.14% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $11 → $15 | $2.26 | +563.72% | 4 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $25 | $2.77 | +802.53% | 1 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $65 | $12.46 | +421.67% | 5 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $5.39 | +85.53% | 2 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $5 | $0.54 | +834.06% | 3 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $152 | $8.32 | +1,726.92% | 2 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $63 → $36 | $20.46 | +75.95% | 4 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $5 → $4 | $3.87 | +3.36% | 3 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $60 | $0.21 | +28,069.01% | 3 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7,200 → $5,400 | $3.43 | +157,334.40% | 2 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $11 | $2.92 | +276.71% | 2 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $18 | $2.41 | +648.44% | 1 | Jul 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $50 | $4.30 | +1,062.79% | 1 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,240 | $1.83 | +176,949.18% | 1 | Feb 4, 2020 |
Sensei Biotherapeutics
Mar 28, 2025
Maintains: Outperform
Price Target: $70 → $80
Current: $7.84
Upside: +920.41%
Abeona Therapeutics
Mar 5, 2025
Initiates: Outperform
Price Target: $16
Current: $6.59
Upside: +142.79%
Ovid Therapeutics
Jan 29, 2025
Upgrades: Outperform
Price Target: $4
Current: $0.55
Upside: +627.27%
Tarsus Pharmaceuticals
Jan 22, 2025
Maintains: Outperform
Price Target: $65 → $72
Current: $43.24
Upside: +66.51%
Harmony Biosciences Holdings
Jan 13, 2025
Maintains: Outperform
Price Target: $59 → $61
Current: $35.20
Upside: +73.30%
Mind Medicine (MindMed)
Dec 17, 2024
Reiterates: Outperform
Price Target: $20
Current: $8.88
Upside: +125.23%
Entrada Therapeutics
Nov 6, 2024
Maintains: Outperform
Price Target: $25 → $28
Current: $6.26
Upside: +347.28%
Avadel Pharmaceuticals
Oct 31, 2024
Maintains: Outperform
Price Target: $29 → $30
Current: $10.83
Upside: +177.01%
Praxis Precision Medicines
Oct 31, 2024
Maintains: Outperform
Price Target: $143 → $163
Current: $53.85
Upside: +202.69%
Dyne Therapeutics
Sep 3, 2024
Reiterates: Outperform
Price Target: $55
Current: $9.02
Upside: +509.76%
Aug 19, 2024
Reiterates: Outperform
Price Target: $15
Current: $5.74
Upside: +161.32%
Aug 16, 2024
Reiterates: Outperform
Price Target: $6
Current: $4.18
Upside: +43.54%
Aug 15, 2024
Reiterates: Outperform
Price Target: $11
Current: $2.68
Upside: +310.45%
Aug 14, 2024
Reiterates: Outperform
Price Target: $14
Current: $15.69
Upside: -10.77%
Aug 9, 2024
Maintains: Outperform
Price Target: $13 → $15
Current: $4.20
Upside: +257.14%
Jun 26, 2024
Maintains: Outperform
Price Target: $11 → $15
Current: $2.26
Upside: +563.72%
Jun 25, 2024
Initiates: Outperform
Price Target: $25
Current: $2.77
Upside: +802.53%
Jun 13, 2024
Maintains: Outperform
Price Target: $55 → $65
Current: $12.46
Upside: +421.67%
May 6, 2024
Reiterates: Outperform
Price Target: $10
Current: $5.39
Upside: +85.53%
Apr 1, 2024
Reiterates: Outperform
Price Target: $5
Current: $0.54
Upside: +834.06%
Aug 30, 2023
Reiterates: Outperform
Price Target: $152
Current: $8.32
Upside: +1,726.92%
Aug 17, 2023
Maintains: Outperform
Price Target: $63 → $36
Current: $20.46
Upside: +75.95%
Apr 4, 2023
Maintains: Outperform
Price Target: $5 → $4
Current: $3.87
Upside: +3.36%
Apr 3, 2023
Maintains: Outperform
Price Target: $100 → $60
Current: $0.21
Upside: +28,069.01%
Feb 6, 2023
Maintains: Outperform
Price Target: $7,200 → $5,400
Current: $3.43
Upside: +157,334.40%
Aug 29, 2022
Maintains: Outperform
Price Target: $17 → $11
Current: $2.92
Upside: +276.71%
Jul 18, 2022
Assumes: Outperform
Price Target: $18
Current: $2.41
Upside: +648.44%
Oct 29, 2021
Initiates: Outperform
Price Target: $50
Current: $4.30
Upside: +1,062.79%
Feb 4, 2020
Initiates: Buy
Price Target: $3,240
Current: $1.83
Upside: +176,949.18%